Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk NeuroblastomaCIRB: Pediatric CIRBLead Group: COGStatus: Closed to Accrual. Pts Still Rcving InterventionReview Status: Available to Open
